Amgen’s Lumakras Falls Short Of Mirati’s Adagrasib In Pancreatic Cancer

Pressure On To Make Most Of Lung Cancer Foothold

 
• By Ayisha Sharma
medically accurate illustration of cancer cell
Just 1% Of Pancreatic Tumors Have A KRAS Mutation. • Source: Alamy

More from Anticancer

More from Therapeutic Category